DrugPatentWatch Database Preview
Details for Patent: 7,989,448
» See Plans and Pricing
Which drugs does patent 7,989,448 protect, and when does it expire?
Patent 7,989,448 protects TAVALISSE and is included in one NDA.
This patent has thirty-four patent family members in twenty-six countries.
Summary for Patent: 7,989,448
Title: | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
Abstract: | The present disclosure provides compounds of the following formula, ##STR00001## and methods of using the compounds to inhibit cellular degranulation and to treat diseases associated therewith. |
Inventor(s): | Singh; Rajinder (Belmont, CA), Bhamidipati; Somasekhar (Foster City, CA), Masuda; Esteban (Menlo Park, CA) |
Assignee: | Rigel Pharmaceuticals, Inc. (South San Francisco, CA) |
Application Number: | 12/268,218 |
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 7,989,448
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-001 | Apr 17, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-002 | Apr 17, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,989,448
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 451381 | Start Trial | |||
Australia | 2006206458 | Start Trial | |||
Brazil | PI0606318 | Start Trial | |||
Canada | 2591948 | Start Trial | |||
China | 101115761 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |